Home › Funds › Morgan Stanley › TEVA
Morgan Stanley position in TEVA
TEVA PHARMACEUTICAL INDS LTD · Health Care
Latest position (Q2 2026)6.97M sh
Reported value held$236.10M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 2.65M | $25.84M | New |
| Q4 2021 | 3.58M | $28.69M | Add |
| Q1 2022 | 3.88M | $36.41M | Add |
| Q2 2022 | 5.87M | $44.15M | Add |
| Q3 2022 | 5.83M | $47.04M | Reduce |
| Q4 2022 | 6.29M | $57.40M | Add |
| Q1 2023 | 4.87M | $43.10M | Reduce |
| Q2 2023 | 6.95M | $52.33M | Add |
| Q3 2023 | 5.81M | $59.25M | Reduce |
| Q4 2023 | 8.23M | $85.87M | Add |
| Q1 2024 | 5.43M | $76.56M | Reduce |
| Q2 2024 | 13.14M | $213.51M | Add |
| Q3 2024 | 13.56M | $244.28M | Add |
| Q4 2024 | 14.91M | $328.64M | Add |
| Q1 2025 | 11.00M | $169.04M | Reduce |
| Q2 2025 | 6.61M | $110.84M | Reduce |
| Q3 2025 | 6.48M | $130.80M | Reduce |
| Q4 2025 | 8.44M | $263.56M | Add |
| Q1 2026 | 7.43M | $223.68M | Reduce |
| Q2 2026 | 6.97M | $236.10M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TEVA
- BlackRock Inc 63.89M sh · $2.16B · Q2 2026
- Norges Bank Investment Management 32.30M sh · $1.09B · Q2 2026
- Fidelity Management & Research (FMR) 30.26M sh · $1.03B · Q2 2026
- Capital World Investors 12.54M sh · $424.72M · Q2 2026
- Geode Capital Management 11.61M sh · $391.01M · Q2 2026
- Northern Trust Corp 7.96M sh · $269.58M · Q2 2026
- Wellington Management Group 7.67M sh · $259.90M · Q2 2026
- Goldman Sachs Group 6.13M sh · $207.66M · Q2 2026
- Janus Henderson Group 4.82M sh · $145.08M · Q1 2026
- Citadel Advisors 4.24M sh · $143.75M · Q2 2026
- Bank of America Corp 4.23M sh · $143.23M · Q2 2026